Cargando…

The stem cell/cancer stem cell marker ALDH1A3 regulates the expression of the survival factor tissue transglutaminase, in mesenchymal glioma stem cells

Tissue transglutaminase (tTG), a dual-function enzyme with GTP-binding and acyltransferase activities, has been implicated in the survival and chemotherapy resistance of aggressive cancer cells and cancer stem cells, including glioma stem cells (GSCs). Using a model system comprising two distinct su...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sullivan, Kelly E., Rojas, Kathy, Cerione, Richard A., Nakano, Ichiro, Wilson, Kristin F.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2017
Materias:	Priority Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5410226/ https://www.ncbi.nlm.nih.gov/pubmed/28423611 http://dx.doi.org/10.18632/oncotarget.16479

Ejemplares similares

Novel function of MDA-9/Syntenin (SDCBP) as a regulator of survival and stemness in glioma stem cells
por: Talukdar, Sarmistha, et al.
Publicado: (2016)

ALDH/CD44 identifies uniquely tumorigenic cancer stem cells in salivary gland mucoepidermoid carcinomas
por: Adams, April, et al.
Publicado: (2015)

Mesenchymal stem cell infiltration during neoplastic transformation of the human prostate
por: Brennen, W. Nathaniel, et al.
Publicado: (2017)

ALDH1A3 in CSCs
por: Sullivan, Kelly E., et al.
Publicado: (2017)

Gene expression profiling distinguishes proneural glioma stem cells from mesenchymal glioma stem cells
por: Chandran, Uma R., et al.
Publicado: (2015)

Telomere DNA damage signaling regulates cancer stem cell evolution, epithelial mesenchymal transition, and metastasis
por: Lagunas, Angelica M., et al.
Publicado: (2017)

Oxidative Phosphorylation Fueled by Fatty Acid Oxidation Sensitizes Leukemic Stem Cells to Cold
por: Griessinger, Emmanuel, et al.
Publicado: (2023)

Mitochondrial biogenesis is required for the anchorage-independent survival and propagation of stem-like cancer cells
por: De Luca, Arianna, et al.
Publicado: (2015)

Molecular properties of CD133+ glioblastoma stem cells derived from treatment-refractory recurrent brain tumors
por: Liu, Qinghai, et al.
Publicado: (2009)

Anti-tumoral effect of desmethylclomipramine in lung cancer stem cells
por: Bongiorno-Borbone, Lucilla, et al.
Publicado: (2015)

Glioblastoma and glioblastoma stem cells are dependent on functional MTH1
por: Pudelko, Linda, et al.
Publicado: (2017)

Angiocrine extracellular vesicles impose mesenchymal reprogramming upon proneural glioma stem cells
por: Adnani, Lata, et al.
Publicado: (2022)

Sulforaphane reduces YAP/∆Np63α signaling to reduce cancer stem cell survival and tumor formation
por: Fisher, Matthew L., et al.
Publicado: (2017)

IKK/NF-κB signaling contributes to glioblastoma stem cell maintenance
por: Rinkenbaugh, Amanda L., et al.
Publicado: (2016)

Reduced growth rate of aged muscle stem cells is associated with impaired mechanosensitivity
por: Haroon, Mohammad, et al.
Publicado: (2022)

Type II transglutaminase stimulates epidermal cancer stem cell epithelial-mesenchymal transition
por: Fisher, Matthew L., et al.
Publicado: (2015)

Targeting the SIN3A-PF1 interaction inhibits epithelial to mesenchymal transition and maintenance of a stem cell phenotype in triple negative breast cancer
por: Bansal, Nidhi, et al.
Publicado: (2015)

The deubiquitinase USP54 is overexpressed in colorectal cancer stem cells and promotes intestinal tumorigenesis
por: Fraile, Julia M., et al.
Publicado: (2016)

Expression of the stem cell marker ALDH1 in BRCA1 related breast cancer
por: Heerma van Voss, Marise R., et al.
Publicado: (2011)

Mesenchymal stem cells promote glioma neovascularization in vivo by fusing with cancer stem cells
por: Sun, Chao, et al.
Publicado: (2019)

Targeting tumor-initiating cells: Eliminating anabolic cancer stem cells with inhibitors of protein synthesis or by mimicking caloric restriction
por: Lamb, Rebecca, et al.
Publicado: (2015)

Treatment of advanced gastrointestinal cancer with genetically modified autologous mesenchymal stem cells - TREAT-ME-1 - a phase I, first in human, first in class trial
por: von Einem, Jobst C., et al.
Publicado: (2017)

Oncogenic KRAS activates an embryonic stem cell-like program in human colon cancer initiation
por: Le Rolle, Anne-France, et al.
Publicado: (2016)

Stem cell cultures derived from pediatric brain tumors accurately model the originating tumors
por: Wenger, Anna, et al.
Publicado: (2017)

A small molecule regulator of tissue transglutaminase conformation inhibits the malignant phenotype of cancer cells
por: Katt, William P., et al.
Publicado: (2018)

A framework for educating and empowering students by teaching about history and consequences of bias in STEM
por: Moreau, Corrie S, et al.
Publicado: (2022)

ALDH1A3: A Marker of Mesenchymal Phenotype in Gliomas Associated with Cell Invasion
por: Zhang, Wenlong, et al.
Publicado: (2015)

High mitochondrial mass identifies a sub-population of stem-like cancer cells that are chemo-resistant
por: Farnie, Gillian, et al.
Publicado: (2015)

LATS1/2 kinases trigger self-renewal of cancer stem cells in aggressive oral cancer
por: Nozaki, Masami, et al.
Publicado: (2019)

ZNF131 suppresses centrosome fragmentation in glioblastoma stem-like cells through regulation of HAUS5
por: Ding, Yu, et al.
Publicado: (2017)

Tissue transglutaminase induces Epithelial-Mesenchymal-Transition and the acquisition of stem cell like characteristics in colorectal cancer cells
por: Ayinde, Oluseyi, et al.
Publicado: (2017)

Comparison of Mesenchymal Stem Cell Markers in Multiple Human Adult Stem Cells
por: Maleki, Masoud, et al.
Publicado: (2014)

The rarity of ALDH (+) cells is the key to separation of normal versus leukemia stem cells by ALDH activity in AML patients
por: Hoang, Van T., et al.
Publicado: (2015)

ATM is a key driver of NF-κB-dependent DNA-damage-induced senescence, stem cell dysfunction and aging
por: Zhao, Jing, et al.
Publicado: (2020)

Clinicopathological Significance of Tumor Stem Cell Markers ALDH1 and CD133 in Colorectal Carcinoma
por: Rezaee, Maryam, et al.
Publicado: (2021)

The Expanding Role of Cancer Stem Cell Marker ALDH1A3 in Cancer and Beyond
por: McLean, Meghan E., et al.
Publicado: (2023)

IKK inhibition by BMS-345541 suppresses breast tumorigenesis and metastases by targeting GD2(+) cancer stem cells
por: Battula, Venkata Lokesh, et al.
Publicado: (2017)

A Wnt5a-Cdc42 axis controls aging and rejuvenation of hair-follicle stem cells
por: Tiwari, Rajiv L., et al.
Publicado: (2021)

Differential expression of stem cell markers in proliferating cells in glioma
por: Rehfeld, Marten, et al.
Publicado: (2021)

A specific inhibitor of ALDH1A3 regulates retinoic acid biosynthesis in glioma stem cells
por: Li, Jianfeng, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_cfqqj6f66ot8c7j79qeil5okc9